Quince Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $118.6M | $69.7M |
| FY2022 | $0 | $100.6M | $44.6M |
| FY2023 | $13.4M | $85.1M | $20.8M |
| FY2024 | $14.3M | $30.1M | $6.2M |
| FY2025 | $0 | $-35.7M | $5.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $118.6M | $69.7M |
| FY2022 | $0 | $100.6M | $44.6M |
| FY2023 | $13.4M | $85.1M | $20.8M |
| FY2024 | $14.3M | $30.1M | $6.2M |
| FY2025 | $0 | $-35.7M | $5.8M |